A randomised, double-blind, placebo-controlled phase IIB clinical trial of repeated application of gene therapy in patients with cystic fibrosis: Table 1-Reference-Cited by-同舟云学术

A randomised, double-blind, placebo-controlled phase IIB clinical trial of repeated application of gene therapy in patients with cystic fibrosis: Table 1

Published:2013-03-22 Issue:11 Volume:68 Page:1075-1077
ISSN:0040-6376
Container-title:Thorax
language:en
Short-container-title:Thorax

Author:

Alton Eric W F W,Boyd A Christopher,Cheng Seng H,Cunningham Steve,Davies Jane C,Gill Deborah R,Griesenbach Uta,Higgins Tracy,Hyde Stephen C,Innes J Alastair,Murray Gordon D,Porteous David J

Publisher

BMJ

Subject

Pulmonary and Respiratory Medicine

Reference5 articles.

1. A CFTR potentiator in patients with cystic fibrosis and the G551D mutation;Ramsey;N Engl J Med,2011

2. Gene therapy for cystic fibrosis;Davies;Proc Am Thorac Soc,2010

3. Pre-clinical evaluation of three non-viral gene transfer agents for cystic fibrosis after aerosol delivery to the ovine lung;McLachlan;Gene Ther,2011

4. Cationic lipid-mediated CFTR gene transfer to the lungs and nose of patients with cystic fibrosis: a double-blind placebo-controlled trial;Alton;Lancet,1999

5. CpG-free plasmids confer reduced inflammation and sustained pulmonary gene expression;Hyde;Nat Biotechnol,2008

Cited by 61 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. State-of-the-Art Review on Inhalable Lipid and Polymer Nanocarriers: Design and Development Perspectives;Pharmaceutics;2024-03-01

2. Viral Airway Injury Promotes Cell Engraftment in an In Vitro Model of Cystic Fibrosis Cell Therapy;American Journal of Physiology-Lung Cellular and Molecular Physiology;2023-12-27

3. Harnessing inhaled nanoparticles to overcome the pulmonary barrier for respiratory disease therapy;Advanced Drug Delivery Reviews;2023-11

4. Non-Modulator Therapies;Clinics in Chest Medicine;2022-12

5. Viral Airway Injury Promotes Cell Engraftment in anIn VitroModel of Cystic Fibrosis Cell Therapy;2022-11-15